Influence of pil l burden and drug cost on renal function after transplantation

Pharmacotherapy

Volumn 32, Issue 5, 2012, Pages 427-432

  Hardinger, Karen L ^a   Hutcherson, Timothy ^a   Preston, David ^a   Murillo, Daniel ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Research Medical Center Brookside Campus   (United States)

Author keywords

Adherence; Medication; Pharmacoeconomics; Renal function

Indexed keywords

CORTICOSTEROID; MYCOPHENOLIC ACID; TACROLIMUS; THYMOCYTE ANTIBODY; PRESCRIPTION DRUG;

ACUTE GRAFT REJECTION; ADULT; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; DRUG COST; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PILL; PRESCRIPTION; REVIEW; SEX DIFFERENCE; SURGICAL MORTALITY; TREATMENT REFUSAL; ARTICLE; ECONOMICS; ELECTRONIC MEDICAL RECORD; FACTUAL DATABASE; KIDNEY; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION; MIDDLE AGED; PANCREAS TRANSPLANTATION; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; STATISTICS; TIME; TREATMENT OUTCOME;

DATABASES, FACTUAL; DRUG COSTS; ELECTRONIC HEALTH RECORDS; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MEDICATION ADHERENCE; MIDDLE AGED; PANCREAS TRANSPLANTATION; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864614826     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1875-9114.2012.01032.x     Document Type: Review

References (15)

1. Vlaminck H, Maes B, Evers G, et al. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004;4:1509-13.
2. Jarzembowski T, John E, Panaro F, et al. Impact of noncompliance on outcome after pediatric kidney transplantation: An analysis in racial subgroups. Pediatr Transplant 2004;8:367-71.
3. Yen EF, Hardinger K, Brennan DC, et al. Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant 2004;4:1703-8.
4. Gaston RS, Hudson SL, Ward M, et al. Late renal allograft loss: Noncompliance masquerading as chronic rejection. Transplant Proc 1999;31:21S-3S.
5. Butler JA, Roderick P, Mullee M, et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review. Transplantation 2004;77:769-76.
6. Chisholm MA, Kwong WJ, Spivey CA. Associations of characteristics of renal transplant recipients with clinicians' perceptions of adherence to immunosuppressant therapy. Transplantation 2007;9:1145-50.
7. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-310.
8. Loghman-Adham M. Medication noncompliance in patients with chronic disease: Issues in dialysis and renal transplantation. Am J Manag Care 2003;9:155-71.
9. Kiley DJ, Lam CS, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation 1993;55:51-6.
10. Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009;4(6):1089-96. Epub 2009 May 7.
11. Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clin Transplant. 1994;8(6):550-7.
12. Chisholm MA, Lance CE, Mulloy LL. Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients. Am J Health Syst Pharm 2005;62 (17):1775-81.
13. Vanderpoel DR, Hussein MA, Watson-Heidari T, Perry A. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: A retrospective database analysis. Clin Ther 2004;26 (12):2066-75.
14. Frishman WH. Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens. Cardiol Rev. 2007;15(5):257-63.
15. Benner JS, Chapman RH, Petrilla AA, Tang SS, Rosenberg N, Schwartz JS. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. Am J Health Syst Pharm 2009;66 (16):1471-7.